<?xml version="1.0" encoding="UTF-8"?>
<ref id="B11-pharmaceuticals-13-00096">
 <label>11.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Siu</surname>
    <given-names>Y.L.</given-names>
   </name>
   <name>
    <surname>Teoh</surname>
    <given-names>K.T.</given-names>
   </name>
   <name>
    <surname>Lo</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Chan</surname>
    <given-names>C.M.</given-names>
   </name>
   <name>
    <surname>Kien</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Escriou</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Tsao</surname>
    <given-names>S.W.</given-names>
   </name>
   <name>
    <surname>Nicholls</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>Altmeyer</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Peiris</surname>
    <given-names>J.S.M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles</article-title>
  <source>J. Virol.</source>
  <year>2008</year>
  <volume>82</volume>
  <fpage>11318</fpage>
  <lpage>11330</lpage>
  <pub-id pub-id-type="doi">10.1128/JVI.01052-08</pub-id>
  <pub-id pub-id-type="pmid">18753196</pub-id>
 </element-citation>
</ref>
